Panacea Index Logo

Command Palette

Search for a command to run...

Mindfulness therapy for somatization disorder and functional somatic syndromes: analysis of economic consequences alongside a randomized trial.

Journal of psychosomatic research
January 1, 2013
Lone Overby Fjorback et al. (7 authors)
Comparative StudyJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to compare the economic consequences and effectiveness of mindfulness therapy versus enhanced treatment as usual for patients with bodily distress syndrome (BDS).

Results Summary

Mindfulness therapy reduced disability pension rates (25% vs. 45%) and total healthcare costs significantly compared to enhanced treatment as usual. BDS patients also had higher pre-inclusion unemployment and sickness benefit rates than controls.

Population

119 BDS patients (with fibromyalgia, chronic fatigue syndrome, or somatization disorder) and 5950 matched controls.

Effective Dosage

Not specified

Duration

15-month follow-up

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
mindfulness therapy
decrease
disability pension
BDS patients
-
prevent
#1
mindfulness therapy
decrease
societal costs
BDS patients
-
significantly reduce
#2
mindfulness therapy
increase
effectiveness of care
BDS patients
-
increase
#3
mindfulness therapy
decrease
disability pension receipt
BDS patients
25%
reduced
#4
enhanced treatment as usual
decrease
disability pension receipt
BDS patients
45%
reduced
#5
mindfulness therapy or enhanced treatment as usual
decrease
total health care utilization
BDS patients
mean $5325, median $2971 to mean $3644, median $1593
reduced
#6
Abstract

OBJECTIVE: The objective of the present study is to estimate the economic consequences of somatization disorder and functional somatic syndromes such as fibromyalgia and chronic fatigue syndrome, defined as bodily distress syndrome (BDS), when mindfulness therapy is compared with enhanced treatment as usual. METHODS: A total of 119 BDS patients were randomized to mindfulness therapy or enhanced treatment as usual and compared with 5950 matched controls. Register data were analyzed from 10years before their inclusion to 15-month follow-up. The main outcome measures were disability pension at the 15-month follow-up and a reduction in total health care costs. Unemployment and sickness benefit prior to inclusion were tested as possible risk factors. RESULTS: At 15-month follow-up, 25% from the mindfulness therapy group received disability pension compared with 45% from the specialized treatment group (p=.025). The total health care utilization was reduced over time in both groups from the year before inclusion (mean $5325, median $2971) to the year after inclusion (mean $3644, median $1593) (p=.0001). This overall decline was seen in spite of elevated costs due to assessment and mindfulness therapy or enhanced treatment as usual. The BDS patients accumulated significantly more weeks of unemployment and sickness benefit 5 and 10years before inclusion (p<.0001) than the population controls. CONCLUSIONS: Mindfulness therapy may prevent disability pension and it may have a potential to significantly reduce societal costs and increase the effectiveness of care. Accumulated weeks of unemployment and sickness benefit are possible risk factors for BDS.

Medical Subject Headings (MeSH)
AdultAwarenessCognitive Behavioral TherapyCohort StudiesCost-Benefit AnalysisDenmarkDisability EvaluationFeasibility StudiesFemaleFollow-Up StudiesHealth Care CostsHealth Status IndicatorsHumansMaleMeditationMiddle AgedPensionsPsychotherapy, BriefRelaxation TherapySocial SecuritySomatoform DisordersSyndromeTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality80/10
Citation Metrics
Total Citations28
Citations/Year2.3
Relative Citation Ratio1.31
NIH Percentile60.2%
Research Impact Scores
APT Score0.75
Weight Score1.56
Normalized Score0.70
Related Supplements